Cutaneous Surgery in Patients Receiving Warfarin Therapy

  title={Cutaneous Surgery in Patients Receiving Warfarin Therapy},
  author={Joseph Alcalay},
  journal={Dermatologic Surgery},
  • J. Alcalay
  • Published 1 August 2001
  • Medicine
  • Dermatologic Surgery
BACKGROUND Anticoagulant treatment with warfarin is an essential therapy in patients with prosthetic heart valves and atrial fibrillation to prevent thromboemoblisms. The question whether to stop warfarin treatment in patients undergoing cutaneous surgery is debatable. OBJECTIVE To evaluate the outcome of surgery in patients that were treated with warfarin and underwent excisional and Mohs surgeries. METHODS Warfarin therapy was continued in all patients that underwent excisional and Mohs… 

Tables from this paper

Cutaneous Surgery in Patients on Warfarin Therapy

Anticoagulation with warfarin can be safely continued in patients undergoing minor soft tissue procedures, thereby avoiding the risk of potentially devastating thromboembolic events.

Continuing warfarin during cutaneous surgery.

  • P. SugdenH. Siddiqui
  • Medicine
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
  • 2008

Discontinuation of Warfarin Is Unnecessary in Total Knee Arthroplasty

The data presented suggest maintaining a therapeutic warfarin regimen throughout the perioperative period for high-risk patients is not associated with an increase risk of complications after TKA.

Anticoagulant complications in facial plastic and reconstructive surgery.

This study demonstrates that patients who undergo facial plastic surgery may continue taking antiplatelet and/or anticoagulation therapy during the perioperative period safely with minimal serious complications.

Complications in skin grafts when continuing antithrombotic therapy prior to cutaneous surgery requiring skin grafting: A systematic review

Most of the reviewed studies suggest that the use of antithrombotic therapy can increase the risk of bleeding complications in skin grafts, and care should be taken when operating on anticoagulated patients undergoing cutaneous surgery requiring skin grafting.

A Meta‐analysis of Complications Attributed to Anticoagulation among Patients following Cutaneous Surgery

  • Kevan G. LewisR. Dufresne
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2008
It is suggested that while low, the risk of bleeding among anticoagulated patients may be higher than baseline, and particular emphasis should be placed on examining the effect of combination antICOagulant therapy as well as herbal agents with anticogulant properties on risk of bleed after cutaneous surgery.

Hemorrhagic complications of cutaneous surgery for patients taking antithrombotic therapy: a systematic review and meta-analysis

The evidence regarding the risk of hemorrhage and thromboembolic events for patients undergoing cutaneous surgery while taking antithrombotic therapy is synthesized.

Continuation of medically necessary aspirin and warfarin during cutaneous surgery.

  • C. Otley
  • Medicine
    Mayo Clinic proceedings
  • 2003
In light of the absence of benefit and the presence of risks associated with discontinuation of warfarin and aspirin perioperatively during excisional cutaneous surgery, continuation of these medications is recommended in most situations.

Arthroscopy on anticoagulated patients: a retrospective evaluation of postoperative complications.

Oral warfarin appeared to be a safe alternative to manipulating anticoagulation during the preoperative period for simple arthroscopic procedures, and few surgical bleeding complications were identified.



Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs.

Cutaneous surgery in patients who receive warfarin or platelet inhibitors is associated with a low risk of severe complications, not significantly reduced by brief preoperative discontinuation.

Myths of dental surgery in patients receiving anticoagulant therapy.

  • M. Wahl
  • Medicine
    Journal of the American Dental Association
  • 2000
Dentists should recommend that therapeutic levels of anticoagulation be continued for patients undergoing dental surgery, and practitioners should consult with the patient's physician if necessary to determine his or her level of antICOagulation before performing dental surgery.

Postoperative stroke after stopping warfarin for cutaneous surgery.

  • C. SchanbacherR. Bennett
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2000
Warfarin should not be discontinued prior to cutaneous surgery because of the risk of thromboembolic stroke, although it is commonly believed that continuing warfarin during surgery is associated with an increased bleeding risk, this risk is extremely low and can be easily managed.

Intraoperative and Postoperative Bleeding Problems in Patients Taking Warfarin, Aspirin, and Nonsteroidal Antiinflammatory Agents: A Prospective Study

  • E. BillingsleyM. Maloney
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 1997
It may not be necessary to discontinue aspirin, warfarin, or nonsteroidal antiinflammatory agents in patients undergoing many common dermatologic surgical procedures, such as Mohs surgery, when compared with controls.

Simple and Safe Method to Prepare Patients With Prosthetic Heart Valves for Surgical Dental Procedures

Two days' warfarin suspension is a simple and safe policy for patients with prosthetic heart valves undergoing dental surgery and returns to the therapeutic range in 90% of cases.

Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy.

Transurethral resection can be carried out safely by an experienced urologist on patients anticoagulated with warfarin, reducing the risk of serious thromboembolic complications associated with withdrawal of anticoAGulation.

Consensus guidelines for warfarin therapy: Recommendations from the Australasian Society of Thrombosis and Haemostasis

The anticoagulant effect of warfarin should be kept at an international normalised ratio (INR) of about 2.5 (desirable range, 2.0‐3.0), although a higher level may be better in a few clinical

Warfarin and cataract extraction.

Ten cataract extractions were performed on eight patients for whom warfarin was not discontinued prior to surgery. Three were complicated by hyphaema. No retrobulbar haemorrhages occurred in the four

The international normalized ratio. A guide to understanding and correcting its problems.

In this communication, directed to practicing clinicians, the potential problems with the INR system are discussed, their clinical relevance is critically reviewed, and solutions are offered.